Itron, Inc. (NASDAQ:ITRI) is Aristotle Capital Boston LLC's 5th Largest Position

Aristotle Capital Boston LLC decreased its stake in shares of Itron, Inc. (NASDAQ:ITRI - Free Report) by 11.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 560,938 shares of the scientific and technical instruments company's stock after selling 71,697 shares during the quarter. Itron comprises about 2.3% of Aristotle Capital Boston LLC's portfolio, making the stock its 5th largest holding. Aristotle Capital Boston LLC owned approximately 1.24% of Itron worth $60,907,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the company. First Trust Advisors LP grew its stake in shares of Itron by 9.1% in the 4th quarter. First Trust Advisors LP now owns 802,584 shares of the scientific and technical instruments company's stock worth $87,145,000 after buying an additional 66,637 shares in the last quarter. Norges Bank bought a new stake in Itron in the fourth quarter worth about $64,615,000. Northern Trust Corp grew its stake in shares of Itron by 11.4% during the fourth quarter. Northern Trust Corp now owns 572,266 shares of the scientific and technical instruments company's stock valued at $62,137,000 after buying an additional 58,546 shares during the last quarter. Vontobel Holding Ltd. raised its holdings in shares of Itron by 8.1% in the fourth quarter. Vontobel Holding Ltd. now owns 464,787 shares of the scientific and technical instruments company's stock worth $50,467,000 after buying an additional 34,842 shares during the period. Finally, Arrowstreet Capital Limited Partnership lifted its stake in shares of Itron by 85.7% during the 4th quarter. Arrowstreet Capital Limited Partnership now owns 425,484 shares of the scientific and technical instruments company's stock worth $46,199,000 after acquiring an additional 196,396 shares during the last quarter. 96.19% of the stock is currently owned by institutional investors.

Itron Stock Down 0.4 %

Shares of ITRI stock traded down $0.39 during trading hours on Wednesday, reaching $106.29. 507,882 shares of the company's stock were exchanged, compared to its average volume of 567,249. The stock has a market cap of $4.84 billion, a PE ratio of 21.78, a PEG ratio of 0.81 and a beta of 1.31. The company has a current ratio of 3.36, a quick ratio of 2.83 and a debt-to-equity ratio of 0.91. The stock's fifty day moving average price is $104.36 and its two-hundred day moving average price is $107.49. Itron, Inc. has a 1 year low of $90.11 and a 1 year high of $124.90.

Itron (NASDAQ:ITRI - Get Free Report) last released its earnings results on Thursday, May 1st. The scientific and technical instruments company reported $1.52 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.30 by $0.22. Itron had a return on equity of 19.03% and a net margin of 9.37%. The firm had revenue of $607.15 million for the quarter, compared to the consensus estimate of $608.86 million. During the same period in the prior year, the firm earned $1.24 EPS. The firm's revenue was up .6% on a year-over-year basis. Research analysts predict that Itron, Inc. will post 5.33 EPS for the current year.

Insider Activity at Itron

In other news, CAO David Marshall Wright sold 317 shares of the firm's stock in a transaction dated Monday, February 24th. The stock was sold at an average price of $92.90, for a total transaction of $29,449.30. Following the sale, the chief accounting officer now directly owns 8,108 shares in the company, valued at $753,233.20. This trade represents a 3.76 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP Christopher E. Ware sold 648 shares of the business's stock in a transaction that occurred on Monday, February 24th. The shares were sold at an average price of $92.90, for a total value of $60,199.20. Following the completion of the sale, the senior vice president now owns 20,326 shares of the company's stock, valued at $1,888,285.40. This trade represents a 3.09 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 9,187 shares of company stock worth $945,620. 1.45% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

Several research analysts recently commented on ITRI shares. Canaccord Genuity Group raised their price target on shares of Itron from $130.00 to $132.00 and gave the stock a "buy" rating in a research note on Wednesday, February 26th. Guggenheim reiterated a "buy" rating and issued a $133.00 price target on shares of Itron in a report on Thursday, April 17th. Piper Sandler reduced their price objective on Itron from $124.00 to $121.00 and set a "neutral" rating on the stock in a report on Monday. Oppenheimer raised their price target on Itron from $124.00 to $131.00 and gave the company an "outperform" rating in a research note on Wednesday, February 26th. Finally, StockNews.com downgraded shares of Itron from a "strong-buy" rating to a "buy" rating in a research note on Saturday, March 1st. Three research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average price target of $127.36.

Itron Profile

Itron, Inc, a technology, solutions, and service company, provides end-to-end solutions that help manage energy, water, and smart city operations worldwide. It operates in three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing, such as standard gas, electricity, water, and communicating meters, as well as heat and allocation products.